Geert Cauwenbergh is President at RXi Pharmaceuticals Corp (RXII). They have made 56 open-market trades across 2 companies since 2006, most recently 2023-02-17.
CIK 0001285648
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
56 open-market purchases totalling $265K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RXII | BUY | 2017-10-02 | 2017-10-02 | $0.45 | $4K | N/A | N/A | N/A |
| RXII | BUY | 2017-08-24 | 2017-08-24 | $0.55 | $6K | N/A | N/A | N/A |
| RXII | BUY | 2017-06-22 | 2017-06-22 | $0.63 | $6K | N/A | N/A | N/A |
| RXII | BUY | 2017-04-26 | 2017-04-26 | $0.65 | $7K | N/A | N/A | N/A |
| RXII | BUY | 2017-03-17 | 2017-03-20 | $0.77 | $8K | N/A | N/A | N/A |
| RXII | BUY | 2017-02-17 | 2017-02-21 | $0.69 | $7K | N/A | N/A | N/A |
| RXII | BUY | 2017-02-08 | 2017-02-08 | $0.69 | $7K | N/A | N/A | N/A |
| RXII | BUY | 2017-01-25 | 2017-01-26 | $0.70 | $7K | N/A | N/A | N/A |
| RXII | BUY | 2017-01-19 | 2017-01-19 | $0.70 | $7K | N/A | N/A | N/A |
| RXII | BUY | 2015-04-02 | 2015-04-02 | $0.72 | $4K | N/A | N/A | N/A |
| RXII | BUY | 2015-02-17 | 2015-02-18 | $1.17 | $5K | N/A | N/A | N/A |
| RXII | BUY | 2015-02-10 | 2015-02-11 | $1.24 | $2K | N/A | N/A | N/A |
| RXII | BUY | 2015-01-20 | 2015-01-20 | $1.03 | $10K | N/A | N/A | N/A |
| RXII | BUY | 2014-12-30 | 2014-12-31 | $1.59 | $4K | N/A | N/A | N/A |
| RXII | BUY | 2014-10-13 | 2014-10-14 | $1.68 | $5K | N/A | N/A | N/A |
| RXII | BUY | 2014-09-19 | 2014-09-23 | $2.20 | $10K | N/A | N/A | N/A |
| RXII | BUY | 2014-09-16 | 2014-09-16 | $2.08 | $10K | N/A | N/A | N/A |
| RXII | BUY | 2014-09-15 | 2014-09-15 | $2.19 | $22K | N/A | N/A | N/A |
| RXII | BUY | 2014-07-15 | 2014-07-17 | $2.50 | $3K | N/A | N/A | N/A |
| RXII | BUY | 2014-07-09 | 2014-07-09 | $2.57 | $4K | N/A | N/A | N/A |
| RXII | BUY | 2014-07-02 | 2014-07-02 | $2.86 | $6K | N/A | N/A | N/A |
| RXII | BUY | 2014-06-25 | 2014-06-26 | $3.01 | $2K | N/A | N/A | N/A |
| RXII | BUY | 2014-06-19 | 2014-06-19 | $2.98 | $6K | N/A | N/A | N/A |
| RXII | BUY | 2014-06-09 | 2014-06-09 | $3.05 | $3K | N/A | N/A | N/A |
| RXII | BUY | 2014-06-04 | 2014-06-05 | $2.94 | $6K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.